Latest News
ICON Acquires MedPass International to Enhance Medical Device and Diagnostic Research Services in Europe
Monday 24 February 2020

24 February 2020 - Ireland-based drug and device development company ICON plc (NASDAQ: ICLR) has acquired Paris-based medical device development provider MedPass International, to deepen existing advisory capabilities in medical device regulation, the company said.
Terms of the transaction were not disclosed.
The integration of MedPass International's services brings noted expertise in complex class 3 medical devices, interventional cardiology and structural heart devices.
MedPass International a medical device CRO, regulatory and reimbursement consultancy, that specialises in medical device development and market access.
ICON plc is a provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations.
The company specialises in the strategic development, management and analysis of programmes that support clinical development.
Date Published: 24/02/2020
Target: MedPass International
Country: France
Sector: Healthcare
Type: Corporate acquisition
Status: Closed
Buyer: ICON plc
Terms of the deal were not disclosed